C2CD4B: A Potential Drug Target and Biomarker for Chronic Pain

Target Name: C2CD4B

NCBI ID: G388125

C2CD4B

C2CD4B: A Potential Drug Target and Biomarker for Chronic Pain

Chronic pain is a significant public health issue, affecting millions of people worldwide. The persistent nature of pain can have a significant impact on an individual's quality of life and overall well-being. In addition, chronic pain can also lead to other comorbidities, such as depression, anxiety, and cardiovascular disease. Therefore, the development of new treatments and biomarkers for chronic pain is of great interest.

C2CD4B: A protein with Potential as a Drug Target

The C2CD4B protein is a member of the superfamily of calcium-dependent chloride channels, which are involved in a wide range of physiological processes, including muscle contractions, nerve function, and inflammation. The C2CD4B protein was identified as a potential drug target for chronic pain due to its unique structure and its involvement in pain signaling.

C2CD4B is expressed in various tissues, including brain, spinal cord, muscle, and peripheral nerves. It is involved in the regulation of pain signaling, which is a critical function of the nervous system. The C2CD4B protein is known to play a role in the regulation of neurotransmitter release, which is critical for the transmission of pain signals from the pain receptor to the brain.

In addition, C2CD4B is also involved in the regulation of pain modulation, which is the process by which the brain and spinal cord adapt to chronic pain. The C2CD4B protein is known to play a role in the regulation of pain modulation by modulating the activity of GABA, a neurotransmitter that plays a critical role in the regulation of pain signaling.

C2CD4B as a Biomarker for Chronic Pain

The C2CD4B protein is also potential biomarker for chronic pain due to its expression and involvement in pain signaling. The C2CD4B protein is known to be expressed in various tissues and is involved in the regulation of pain signaling, which is a critical function of the nervous system. Therefore, the C2CD4B protein can be used as a biomarker for chronic pain.

C2CD4B is involved in the regulation of pain signaling by modulating the activity of GABA, a neurotransmitter that plays a critical role in the regulation of pain signaling. Therefore, changes in the expression and activity of C2CD4B can be an indication of chronic pain. For example, reduced expression and activity of C2CD4B can be an indication of chronic pain, while increased expression and activity can be an indication of neuroinflammation.

In addition, the C2CD4B protein is involved in the regulation of pain modulation, which is the process by which the brain and spinal cord adapt to chronic pain. Therefore, changes in the expression and activity of C2CD4B can also be an indication of chronic pain. For example, increased expression and activity of C2CD4B can be an indication of chronic pain, while decreased expression and activity can be an indication of neuroplasticity.

Conclusion

In conclusion, C2CD4B is a protein with potential as a drug target for chronic pain due to its unique structure and its involvement in pain signaling. The C2CD4B protein is expressed in various tissues and is involved in the regulation of pain signaling, which is a critical function of the nervous system. Therefore, changes in the expression and activity of C2CD4B can be used as biomarkers for chronic pain. Further research is needed to determine the role of C2CD4B as a drug target for chronic pain and to develop new treatments for chronic pain.

Protein Name: C2 Calcium Dependent Domain Containing 4B

Functions: May be involved in inflammatory process. May regulate cell architecture and adhesion

The "C2CD4B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C2CD4B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets